BNP Paribas Financial Markets Buys 35,771 Shares of ESSA Pharma Inc. (NASDAQ:EPIX)

BNP Paribas Financial Markets grew its holdings in shares of ESSA Pharma Inc. (NASDAQ:EPIXFree Report) (TSE:EPI) by 164.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 57,466 shares of the company’s stock after buying an additional 35,771 shares during the period. BNP Paribas Financial Markets owned 0.13% of ESSA Pharma worth $379,000 as of its most recent SEC filing.

Separately, Rock Springs Capital Management LP grew its stake in ESSA Pharma by 2.1% in the third quarter. Rock Springs Capital Management LP now owns 677,005 shares of the company’s stock worth $2,092,000 after purchasing an additional 13,688 shares during the period. Institutional investors own 75.12% of the company’s stock.

ESSA Pharma Price Performance

Shares of ESSA Pharma stock opened at $5.77 on Wednesday. ESSA Pharma Inc. has a 1 year low of $2.58 and a 1 year high of $11.67. The firm’s 50-day moving average is $6.89 and its 200 day moving average is $7.48. The stock has a market cap of $255.96 million, a price-to-earnings ratio of -9.16 and a beta of 1.81.

Wall Street Analyst Weigh In

Separately, Oppenheimer reaffirmed an “outperform” rating and issued a $17.00 price target on shares of ESSA Pharma in a research note on Thursday, May 16th.

Check Out Our Latest Stock Analysis on ESSA Pharma

ESSA Pharma Company Profile

(Free Report)

ESSA Pharma Inc, a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer.

Read More

Want to see what other hedge funds are holding EPIX? Visit to get the latest 13F filings and insider trades for ESSA Pharma Inc. (NASDAQ:EPIXFree Report) (TSE:EPI).

Institutional Ownership by Quarter for ESSA Pharma (NASDAQ:EPIX)

Receive News & Ratings for ESSA Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ESSA Pharma and related companies with's FREE daily email newsletter.